No Data
Analysts Offer Insights on Healthcare Companies: Clene (CLNN) and Allakos (ALLK)
Express News | Allakos Says First Patient Has Been Dosed In Phase 1 Trial Of AK006 In Chronic Spontaneous Urticaria
Express News | Allakos Inc - Top-Line Phase 1 Csu Results Expected at Year End 2024
Express News | Allakos Announces First Patient Dosed in Phase 1 Trial of Ak006 in Chronic Spontaneous Urticaria
Analysts Have Conflicting Sentiments on These Healthcare Companies: ARS Pharmaceuticals (SPRY), AnaptysBio (ANAB) and Allakos (ALLK)
Allakos Inc. Reports Increased Losses in Q1 2024, Misses Analyst Earnings Predictions